During the past decade, Christine Codding, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Christine Codding, MD" are "Low Back Pain" (2 trials), "Arthritis" (1 trials) and "Osteoarthritis" (1 trials). Many other conditions were trialed in "Christine Codding, MD" in a lesser frequency.

Most popular intervention types in "Christine Codding, MD" are "Biological" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "NSAID" (1 trials), "Naproxen" (1 trials), "Placebo for naproxen" (1 trials), "Placebo for tanezumab" (1 trials) and "Tanezumab 10 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Christine Codding, MD" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Christine Codding, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Christine Codding, MD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Christine Codding, MD, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".